All In MedTech

Device Trial Radar · NCT02438475

The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure

Last checked: Nov 20, 2026Latest source record: Nov 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 208 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

208

Actual

Start

Jun 2015

Primary completion

Aug 2017

Study completion Aug 2017

Sponsor

Lead sponsor
Medstar Health Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Cardinal Health
First posted
May 8, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Evaluate the safety of the MynxGrip™ extravascular sealant for common femoral vein closure following both diagnostic and interventional procedures as assessed by clinical and imaging criteria.

Conditions

  • Cardiac Diagnostic Procedure
  • Cardiac Interventional Procedure
  • Femoral Access Site Closure

Interventions

  • Mynx Vascular Closure SystemDevice

    MynxGrip is being used to seal femoral vein access sites while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures utilizing a 5F, 6F or 7F procedural sheath.

  • Manual CompressionOther

    manual pressure applied to your groin for approximately 5-10 minutes

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of Venous ThrombosisTime frame: Subjects will be followed up until their discharge from the hospital, and expected average of 24 hours
  2. Bleeding or Vascular Related ComplicationsTime frame: Subjects will be followed up until their discharge from the hospital, and expected average of 24 hours
  3. Device/Procedure FailureTime frame: intraoperative

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia

  • MedStar Southern Maryland Hospital

    Clinton, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.